Quarterly report · Q1
4005.TEDINET S100RJX5
Period2023-04-01 → 2023-06-30
Filed2023-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥563.1bn | 2023-04-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥2.90T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥774.1bn | 2022-04-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Operating income | −¥71.7bn | 2023-04-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥66.3bn | 2022-04-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥49.9bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥231m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥113.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥33.2bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥7.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥70.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥51.2bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥46.9bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥85.1bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥4.37T | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥4.17T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥4.67T | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.82T | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.68T | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.55T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.49T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.86T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.70T | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.22T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.17T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.34T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥323.1bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥305.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥498.6bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥365.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥131.9bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥111.6bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥42.6bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥13.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥19.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥46.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥142.0bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥178.5bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥11.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-20.27 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥4.27 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥42.81 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥4.27 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Equity ratio | 28.0% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.1% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 28.8% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥37.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥17.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥20.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | ¥2.4bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥27.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥27.9bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥4.4bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥78.8bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥73.4bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.0bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥193.7bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥192.4bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥21.0bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥103.5bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥102.7bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥762m |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥7.0bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥94.6bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥94.5bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥110m |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥6.7bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥83.0bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥83.0bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥33.3bn |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥553.6bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥545.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥7.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | −¥51.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥31.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥14.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥17.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥3.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥24.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥24.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.5bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥91.3bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥86.4bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥4.8bn |
| jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥6.6bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥240.0bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥238.6bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥10.0bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥153.5bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥152.6bn |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥945m |
| jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥21.9bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥114.8bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥114.7bn |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥116m |
| jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥15.8bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥167.7bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥167.7bn |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E00752-000Medical Productsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥14.1bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥767.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥759.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥7.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥68.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 840
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in trade payables ope cf IFRS | Prior1YTDDuration | 62567000000 | JPY |
| Increase decrease in trade payables ope cf IFRS | CurrentYTDDuration | -22303000000 | JPY |
| Increase decrease in unearned revenue ope cf IFRS | Prior1YTDDuration | -8119000000 | JPY |
| Increase decrease in unearned revenue ope cf IFRS | CurrentYTDDuration | -2927000000 | JPY |
| Increase decrease in provisions ope cf IFRS | Prior1YTDDuration | 9446000000 | JPY |
| Increase decrease in provisions ope cf IFRS | CurrentYTDDuration | -35791000000 | JPY |
| Other changes in working capital ope cf IFRS | Prior1YTDDuration | -117487000000 | JPY |
| Other changes in working capital ope cf IFRS | CurrentYTDDuration | -82192000000 | JPY |
| Subtotal ope cf IFRS | Prior1YTDDuration | 63789000000 | JPY |
| Subtotal ope cf IFRS | CurrentYTDDuration | -102634000000 | JPY |
| Interest and dividends received ope cf IFRS | Prior1YTDDuration | 8845000000 | JPY |
| Interest and dividends received ope cf IFRS | CurrentYTDDuration | 9034000000 | JPY |
| Interest paid ope cf IFRS | Prior1YTDDuration | -6013000000 | JPY |
| Interest paid ope cf IFRS | CurrentYTDDuration | -6875000000 | JPY |
| Income taxes paid ope cf IFRS | Prior1YTDDuration | -22864000000 | JPY |
| Income taxes paid ope cf IFRS | CurrentYTDDuration | -30749000000 | JPY |
| Business structure improvement expenses paid ope cf IFRS | Prior1YTDDuration | -1126000000 | JPY |
| Business structure improvement expenses paid ope cf IFRS | CurrentYTDDuration | -694000000 | JPY |
| Net cash provided by used in operating activities IFRS | Prior1YTDDuration | 42631000000 | JPY |
| Net cash provided by used in operating activities IFRS | CurrentYTDDuration | -131918000000 | JPY |
| Decease increase of marketable securities inv cf IFRS | Prior1YTDDuration | -10591000000 | JPY |
| Decease increase of marketable securities inv cf IFRS | CurrentYTDDuration | -4599000000 | JPY |
| Purchase of non current assets inv cf IFRS | Prior1YTDDuration | -37490000000 | JPY |
| Purchase of non current assets inv cf IFRS | CurrentYTDDuration | -44188000000 | JPY |
| Proceeds from sales of non current assets inv cf IFRS | Prior1YTDDuration | 2154000000 | JPY |
| Proceeds from sales of non current assets inv cf IFRS | CurrentYTDDuration | 430000000 | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from sale of subsidiaries inv cf IFRS | CurrentYTDDuration | 11074000000 | JPY |
| Purchase of investments inv cf IFRS | Prior1YTDDuration | -3007000000 | JPY |
| Purchase of investments inv cf IFRS | CurrentYTDDuration | -2343000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | Prior1YTDDuration | 36186000000 | JPY |
| Proceeds from sale of investments inv cf IFRS | CurrentYTDDuration | 24788000000 | JPY |
| Collection of loans receivable inv cf IFRS | Prior1YTDDuration | 59900000000 | JPY |
| Collection of loans receivable inv cf IFRS | CurrentYTDDuration | 235000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | -1127000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | 1164000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | 46025000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -13439000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | Prior1YTDDuration | 46613000000 | JPY |
| Net increase decrease in short term borrowings fin cf IFRS | CurrentYTDDuration | 79406000000 | JPY |
| Net increase decrease in commercial paper fin cf IFRS | Prior1YTDDuration | 40000000000 | JPY |
| Net increase decrease in commercial paper fin cf IFRS | CurrentYTDDuration | 53000000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1YTDDuration | 716000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | CurrentYTDDuration | 29956000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | Prior1YTDDuration | -38873000000 | JPY |
| Repayments of long term borrowings fin cf IFRS | CurrentYTDDuration | -1815000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -4259000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -4340000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -22900000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -9821000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |